084440 — U Bion Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapNeutral

Annual income statement for U Bion Co, fiscal year end - September 30th, KRW millions except per share, conversion factor applied.

	R2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	22,646	28,067	31,461	31,832	33,282
Cost of Revenue
Gross Profit	9,965	12,120	14,369	13,174	12,362
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	21,370	26,343	29,116	31,450	35,396
Operating Profit	1,276	1,724	2,345	381	-2,114
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	84.4	1,440	1,974	-748	-3,466
Provision for Income Taxes
Net Income After Taxes	36.3	1,441	2,151	-601	-2,800
Minority Interest
Net Income Before Extraordinary Items
Net Income	36.3	1,441	2,151	-544	-2,800
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	36.3	1,441	2,151	-544	-2,800
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.73	96.1	128	-27.5	-139
Dividends per Share